Univercells Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 450

Employees

  • Latest Deal Type
  • Out of Business

Univercells General Information

Description

Developer of vaccines and bio-therapeutics designed to address global health challenges. The company offers integrated biomanufacturing platforms, compact automated RNA/DNA processing technology, single-use high-density production systems, and end-to-end manufacturing services to transform how biologic drugs, vaccines, and therapies are produced and distributed, enabling global biotech and pharmaceutical developers to produce biologics more affordably and make them accessible to patients everywhere.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Avenue Centrale 52
  • Zoning de Jumet
  • 6040 Gosselies
  • Belgium
+32 02
Primary Industry
Holding Companies
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Avenue Centrale 52
  • Zoning de Jumet
  • 6040 Gosselies
  • Belgium
+32 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Univercells Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Out of Business 25-Jun-2026 Completed Out of Business
13. Later Stage VC 01-Aug-2023 Completed Generating Revenue
12. Later Stage VC (Series D) 19-Oct-2022 Completed Generating Revenue
11. Later Stage VC 21-Jan-2022 Completed Generating Revenue
10. Debt - General 24-Jun-2021 Completed Generating Revenue
9. Later Stage VC (Series C) 17-Dec-2020 Completed Generating Revenue
8. Debt - General 25-Sep-2019 Completed Generating Revenue
7. Grant 15-Jun-2019 Completed Generating Revenue
6. Later Stage VC (Series B) 16-Jul-2018 $18.6M $25.6M Completed Generating Revenue
5. Grant 23-Jan-2018 $2.9M $6.99M Completed Startup
To view Univercells’s complete valuation and funding history, request access »

Univercells Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class D
Class C
Class C
Class B 483,796 $36.5 $36.5 1x $36.5 15.07%
Class A 304,673 $22.12 $22.12 1x $22.12 9.49%
To view Univercells’s complete cap table history, request access »

Univercells Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vaccines and bio-therapeutics designed to address global health challenges. The company offers integrated b
Holding Companies
Gosselies, Belgium
450 As of 2023

Berlin, Germany
 

Madrid, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Univercells Competitors (16)

One of Univercells’s 16 competitors is Glycotope, a Formerly VC-backed company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glycotope Formerly VC-backed Berlin, Germany
mAbxience Corporate Backed or Acquired Madrid, Spain
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Biovest International Formerly VC-backed Coon Rapids, MN
CordenPharma Private Equity-Backed Basel, Switzerland
You’re viewing 5 of 16 competitors. Get the full list »

Univercells Patents

Univercells Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026037882-A2 Apparatus for culturing shear sensitive cells and related methods Pending 14-Aug-2024
WO-2026037882-A3 Apparatus for culturing shear sensitive cells and related methods Pending 14-Aug-2024
WO-2026013277-A1 Unit and method for executing a bioprocessing step Pending 12-Jul-2024
WO-2026012929-A1 Apparatus for cell culturing and related methods Pending 07-Jul-2024
EP-4619499-A2 Systems and methods for recovering target biomolecules from fixed bed bioreactors Pending 18-Nov-2022 C12M27/16
To view Univercells’s complete patent history, request access »

Univercells Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Univercells Acquisitions (1)

Univercells’s most recent deal was a Merger/Acquisition with SynHelix. The deal was made on 06-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SynHelix 06-Jan-2022 Merger/Acquisition Discovery Tools (Healthcare)
To view Univercells’s complete acquisitions history, request access »

Univercells Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Quantoom Biosciences Nivelles, Belgium 2021
UNIZIMA Jumet, Belgium 2020
Exothera Nivelles, Belgium 2020
SynHelix Évry-Courcouronnes, France 2019
Rlm Consulting Nivelles, Belgium 2006

Univercells FAQs

  • When was Univercells founded?

    Univercells was founded in 2013.

  • Where is Univercells headquartered?

    Univercells is headquartered in Gosselies, Belgium.

  • What is the size of Univercells?

    Univercells has 450 total employees.

  • What industry is Univercells in?

    Univercells’s primary industry is Holding Companies.

  • Is Univercells a private or public company?

    Univercells is a Private company.

  • What is Univercells’s current revenue?

    The current revenue for Univercells is .

  • How much funding has Univercells raised over time?

    Univercells has raised $239M.

  • Who are Univercells’s competitors?

    Glycotope, mAbxience, Cellaion, Biovest International, and CordenPharma are some of the 16 competitors of Univercells.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process